Back
Brainstorm Cell Therapeutics Stock Price Chart
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
8
BCLI
Brainstorm Cell Therapeutics
Last Price:
2.23
Seasonality Move:
-7.58%
7 Day Trial
ALL ACCESS PASS
$
7
Why Over 21,997 Investors Are Flocking to This Opportunity
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BCLI is experiencing slight selling pressure.
Brainstorm Cell Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.15 | Sell |
| 20-day SMA: | 3.59 | Sell |
| 50-day SMA: | 4.27 | Sell |
| 200-day SMA: | 5.74 | Sell |
| 8-day EMA: | 3 | Sell |
| 20-day EMA: | 3.5 | Sell |
| 50-day EMA: | 4.22 | Sell |
| 200-day EMA: | 7.23 | Sell |
Brainstorm Cell Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.47 | Sell |
| Relative Strength Index (14 RSI): | 24.28 | Sell |
| Chaikin Money Flow: | -18150 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.17 - 4.27) | Sell |
| Bollinger Bands (100): | (3.91 - 6.79) | Sell |
Brainstorm Cell Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Brainstorm Cell Therapeutics Stock
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 2.34 while BCLI 8-day simple moving average is 3.15, which is a Sell signal.
- The stock price of BCLI is 2.34 while Brainstorm Cell Therapeutics 20-day SMA is 3.59, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day simple moving average is 4.27 while BCLI share price is 2.34, making it a Sell technically.
- BCLI stock price is 2.34 and Brainstorm Cell Therapeutics 200-day simple moving average is 5.74, creating a Sell signal.
BCLI Technical Analysis vs Fundamental Analysis
Sell
8
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Is Brainstorm Cell Therapeutics a Buy or a Sell?
-
Brainstorm Cell Therapeutics stock is rated a Sell
The current Brainstorm Cell Therapeutics [BCLI] share price is $2.34. The Score for BCLI is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
Brainstorm Cell Therapeutics Stock Info
Market Cap:
12.46M
Price in USD:
2.34
Share Volume:
82.46K
Brainstorm Cell Therapeutics 52-Week Range
52-Week High:
11.89
52-Week Low:
2.01
Sell
8
Brainstorm Cell Therapeutics (BCLI)
is a Sell
Brainstorm Cell Therapeutics Share Price Forecast
-
What is the Brainstorm Cell Therapeutics stock price today?
The Brainstorm Cell Therapeutics stock price is 2.34 USD today. -
Will BCLI stock go up or go down?
Brainstorm Cell Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Brainstorm Cell Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Brainstorm Cell Therapeutics is overvalued.
Is Brainstorm Cell Therapeutics Stock a Buy?
- Brainstorm Cell Therapeutics share price is 2.34 while BCLI 8-day exponential moving average is 3.00, which is a Sell signal.
- The stock price of BCLI is 2.34 while Brainstorm Cell Therapeutics 20-day EMA is 3.50, which makes it a Sell.
- Brainstorm Cell Therapeutics 50-day exponential moving average is 4.22 while BCLI share price is 2.34, making it a Sell technically.
- BCLI stock price is 2.34 and Brainstorm Cell Therapeutics 200-day simple moving average is 7.23, creating a Sell signal.
Fundamental Analysis of Brainstorm Cell Therapeutics
Is Brainstorm Cell Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.55 per share, and an increase next year of $0.08 per share.
Technical Analysis of Brainstorm Cell Therapeutics
Should I short Brainstorm Cell Therapeutics stock?
- BCLI Moving Average Covergence Divergence (MACD) indicator is -0.47, suggesting Brainstorm Cell Therapeutics is a Sell
- Brainstorm Cell Therapeutics Relative Strength Index (RSI) is 24.28, which suggest Brainstorm Cell Therapeutics is oversold
- The Bollinger Bands (25) for Brainstorm Cell Therapeutics is (3.17 - 4.27), which suggest Brainstorm Cell Therapeutics is a Sell
- The Bollinger Bands (100) for Brainstorm Cell Therapeutics is (3.91 - 6.79), which suggest Brainstorm Cell Therapeutics is a Sell
* Brainstorm Cell Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.